['The renin-angiotensin system (RAS) depressor arm, particularly renal angiotensin type 2 receptor (AT(2) R) and Mas receptor (masR) expression, is enhanced in females, which may contribute to renal and cardiovascular protection. We examined the hypotheses that masR activation increases renal blood flow (RBF) at rest and attenuates the reduction in RBF in response to angiotensin II (AngII) infusion in female rats. Furthermore, we postulated that combined activation of the AT(2) R and masR would produce a greater response than masR activation alone.', 'In anaesthetized male and female Wistar rats, mean arterial pressure (MAP) and RBF responses during graded AngII infusion (30-1000\xa0ng\xa0kg(-1) \xa0min(-1)  i.v.) were assessed following pre-treatment with vehicle, the masR antagonist A779, or A779 plus the AT(2) R antagonist PD123319.', 'Basal MAP was not altered by any pre-treatment. Basal RBF decreased approx. 20% in female (P\xa0<\xa00.05), but not male rats in response to A779. However, basal RBF was not altered by A779\xa0+\xa0PD123319. AngII infusion reduced RBF in a dose-related fashion (P(dose) \xa0<\xa00.0001) and masR blockade did not alter the RBF response to AngII infusion in male or female rats. However, A779\xa0+\xa0PD123319 attenuated the reduction in RBF response to AngII in females (P(group) \xa0<\xa00.005), but not males.'] Does sex differences in the renal vascular response to angiotensin II involve the Mas receptor?